Mizoribine treatment for childhood IgA nephropathy

Pediatrics International

Volumn 44, Issue 2, 2002, Pages 217-223

  Nagaoka, Rieko ^a   Kaneko, Kazunari ^a   Ohtomo, Yoshiyuki ^a   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Child; Glomerulonephritis; IgA nephropathy; Immunosuppressant; Mizoribine

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MIZORIBINE;

CELL PROLIFERATION; CREATININE URINE LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; URINARY EXCRETION;

ADOLESCENT; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RIBONUCLEOSIDES; TIME FACTORS;

EID: 0036125466     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1328-8067.2001.01532.x     Document Type: Review

References (27)

1. Proceedings of the American Society of Pediatric Nephrology Educational Symposium, May, 1996, Washington, D.C.
2. Evidence-based assessment of treatment options for children with IgA nephropathies
3. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese
4. IgA nephropathy: Long-term prognosis for pediatric patients
5. IgA nephropathy in children from Japan. Clinical and pathological features
6. IgA nephropathy: Perspectives on pathogenesis and classification
7. Immunoregulatory factors in the pathogenesis of IgA nephropathy
8. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy
9. Studies on Bredinin. I. Isolation, characterization and biological properties
10. New immunosuppressive drugs in organ transplantation
11. Mizoribine and mycophenolate mofetil
12. Mizoribine in steroid-dependent nephrotic syndrome of childhood
13. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome
14. Mizoribine for childhood IgA nephropathy
15. Assessment of proteinuria using random urine samples
16. Simplified high-performance liquid chromatographic method for determination of mizoribine in human serum
17. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy
18. Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice
19. Effect of mizoribine on serum IgE concentration in patients with IgA nephropathy
20. Clinical trial of bredinin in renal transplantation
21. Studies on pharmacokinetics of bredinin
22. Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy
23. Involvement of IL-6 in mesangial proliferative glomerulonephritis
24. In situ expression of cytokines in IgA nephritis
25. Urinary IL-6/ EGF ratio: A useful prognostic marker for the progression of renal damage in IgA nephropathy
26. Effect of Mizoribine on IL-6 release by peripheral blood mononuclear cells
27. Inhibitory mechanism of mizoribine on the antibody production of mouse B cells stimulated with lipopoly-saccharide